Reoxi™ Skin Cream Testimonials
The following are real testimonials from actual users of the Reoxi
formula skin repair cream with Imunoglukan®
“I have been using Reoxi skin repair for the last four months and it has
done wonders to my skin. I have seen improvement and good results. It
does not just moisturize and hydrate my skin but it also helps diminish
fine lines, wrinkles and flaws on my face”
-Alpha Mendoza
“Oh my gosh! I just love the Reoxi Skin Repair formula. I use it both in
the morning and at night on my face, neck and upper chest and what a
wonderful Difference it has made. The lines I had around my eyes, lips
and between my eyebrows have reduced dramatically while still leaving my
skin feeling soft and supple. I have been asked on several occasions
what I am using on my face because my skin looks so good. I can’t
believe what a difference it has made from the other skin care products
that I had been using. I will never go back. I am now a customer for
life and will continue to tell all my friends about your magnificent
products.”
-Nancy
“I am writing to tell you how great the (Reoxi) Skin Repair has been for
me. I have never written to a company before, but I feel this product
deserves my opinion. I have noticed a great difference in my skin.
I have been using it every morning and night for about 3 months now. I
cannot help notice the appearance of the reduced fine lines around my
eyes and upper lip. I really love this product and would recommend it to
everyone likes smooth, healthy skin.
I am very pleased with these results. My skin as never looked better.
Thanks for a great Product!”
-Fran Carroll
“Thanks for a great product!!! Since I have been using your product my
skin has never looked so much younger, my children want to know what I
have been doing. My grandkids say, “Grandma your skin feels so soft.”
Thanks again.
-Trish
Individual results may vary, highest achieving results not typical.
How Imunoglukan® Is
Changing Lives All Over The World
“This stuff is amazing! My girlfriends have all been asking me what I am
using! My skin feels so healthy and I love all the compliments.”
—Rachel, Leon, France
“As soon as I put it on I could feel it working... I’ve used products
that cost more than twice as much and the results are the best I’ve ever
seen.”
—Marie, Lisbon, Spain
“After using your wrinkle cream for two weeks, I can see the wrinkles
disappearing from my face. My husband can’t believe how young I look!”
–Gisselle, Stuttgart, Germany
Individual results may vary, highest achieving results not typical.
The
following is a complete Reoxi™ ingredient list and explanation for the
purpose of each particular ingredient:
THIS
PRODUCT IS A PROPRIETARY BLEND OF CELLULAR SKIN REPAIR, ANTI-OXIDANTS
WITH OTHER NATURAL TRACE MINERALS.
INGREDIENT STATEMENT:
DI
Water, Beta Glucan (PluraSAN), Vegetable Glycerine, Capric Caprylic
Triglycerides, Cyclomethicone, Dimethicone/Divinyldimethicone/Silsesquioxane
Crosspolymer, Cyclopentasiloxane, Quaternium-90 Bentonite, Sodium
Polyacrylate, Hydrogenated Polydecene, Trideceth-10, Shea Butter,
Glyceryl Stearate, Peg-100 Stearate, Arachidyl Behenyl Alcohol,
Propylene Carbonate, Carpryloyl Glycine, Undecylinoyl Glycine,
Dipalmityol Hydroxyproline, Perflourohexane, Perflourodecalin,
Phenoxyethanol, Ethylhexylglycerine, EDTA, Hydrolyzed Sesame Protein PG
Propyl Methylsilanediol, Vitamin C and E.
Immunoglukan®
(PluraSAN Beta Glucan)
It is an immune modulating polysaccharide derived from Mushroom that
helps heal skin wounds, eczema. An immune receptor of the skin for
anti-aging and has a soothing effect after cosmetic treatment or acne
treatment.
Capric Caprylic Triglycerides, Cyclomethicone, Dimethicone/Divinyldimethicone/Silsesquioxane
Crosspolymer, Cyclopentasiloxane, Capric Caprilic Triglycerides,
Vegetable Glycerine, Hydrogenated Polydecene, Propylene Carbonate **Emolient
and Humectant
Ageing of the human skin results from loss of elasticity. Less
elasticity means that the epidermis has reduced the ability to absorb
water in order to maintain that natural functioning of the skin.
Quaternium-90 Bentonite
**Provides all the standard benefits of bentonite clays with unique
function of silky skin feel.
Shea Butter, Hydrolyzed Sesame Protein PG Propyl Methylsilanediol
** Anti-inflammatory agent. It provides natural protection on the skin
due to the moisturizer and emollient properties, anti-wrinkles,
can be effective at treating fading scars, severely dry skin, blemishes
and stretch marks.
Carpryloyl Glycine and Undecylinoyl Glycine
**Lipoaminoacid that protects,
regulate and purify skin ecosystem.
Dipalmityol Hydroxyproline
** Has a moisturizing properties that stimulates the contraction of
collagen fiber against free radicals and firming the structure of the
skin due to anti-aging.
Perflourohexane and Perflourodecalin
**It absorbs the oxygen on the cell and cleanse from Carbon dioxide,
refreshing the cellular metabolism of the skin. Components of the liquid
Botox.
Trideceth-10, Glyceryl Stearate, Peg-100 Stearate, Arachidyl Behenyl
Alcohol
**Emulsifier, naturally derived from extractive vegetable origin.
Phenoxyethanol, Ethylhexylglycerine
**Preservatives to prevent free radical damage when oils become rancid.
EDTA Ethylenediamine tetraacetic acid
**Chelating agent
Polysorbate 20
**Solubilizer
Vitamin C and E
** An anti-oxidant that protects body tissue from damage caused by
unstable substances called free radicals.
Imunoglukan®
Detailed Information and Studies
Imunoglukan® cream is used for supportive treatment of problematic, dry,
rough and damaged skin which is less resistant to infection and more
sensitive to various external irritants. It is also used for treatment
of ageing skin (the anti-aging effect), atopic eczema, as a supportive
treatment of acne, dry dermatoses and
chronic stages of rosacea faciei and dermatitis seborrhoica and as a
support of healing of non-infected wounds (varicose ulcers). It
accelerates skin regeneration and skin renewal.
Studies using Immnoglukanbeta-(1,3/1,6)-D-glucan
Beta-(1,3/1,6)-D-Glucan PleraSAN® is a naturally appearing
polysaccharide, isolated for purposes of the Imunoglukan® formulation
from the oyster mushroom (Pleurotus ostreatus). This polysaccharide is
sometimes designated in special literature as „Pleuran”. The basic
characteristic of beta-(1,3/1,6)-D-glucan is its ability to bond to
beta-glucan receptors located on macrophages, neutrophils and monocytes.
Receptor activation of reticuloendothelial system leads to the
activation of phagocytosis. Within only 6 hours after one-shot
administration of beta-(1,3/1,6)- D-glucan, the activation of
phagocytosis can be observed. Maximal activation occurs after 72 hours
and the phagocytosis subsides within 144 hours after the one-shot
administration. Increased amount of vitamin C is needed during the
activation of phagocytosis as the concentration of vitamin C in the
cytoplasm of phagocytes is 40 times higher than in blood. When
activated, macrophages have the ability to secrete more than 100 active
substances in addition to phagocytosis. Some of these (e.g. lysozymes or
parts of the complement) have bactericidal effects. The elastase and
collagenase enzymes, produced
by activated macrophages facilitate cellular migration and accelerate
healing. Activated macrophages also participate in important
immunomodulation processes by secreting several cytokines. For instance,
the colony stimulating factor (GM-CSF) supports growth of haemopoetic
cells.
Imunoglukan®
Studies:
• An in vitro study of efficacy of
glucan PleraSAN® (fromthe company Pleuran) as a stimulator of skin
immunereaction showed a high stimulating potential of
beta-(1,3/1,6)-D-glucan on the production of TNF-alpha cytokine by human
epidermal keratinocytes. TNF-alpha secreted by keratinocytes directly
maintains the viability of Langerhans Cells and favourably influences
the remodeling of tissues and healing of wounds. This glucan thus
represents a therapeutically promising local modulator of skin immune
response. (RNDr. M.Bobovcák, Clinical Laboratory, Department of
Immunology, Military Institute for Respiratory Diseases, Nová Polianka,
Slovakia, 2005)
• Clinical tests indicated
immunomodulating and radioprotective effects of the formulation on
healthy tissues. Reduction in the occurrence of postradiation mucositis
was recorded in patients with head and throat tumors. No side effects
were found during the administration. (MUDr. E.Bolješíková, Head,
Bratislava Clinic for Radiotherapy, Slovakia, 2002)
•
Patients suffering from recurrent paronychia of thumbs
and big toes resistant to conventional conservative as well as surgical
treatment responded positively to Imunoglukan® and showed no
recurrence during application of the formulation. A female patient with
proven immunodeficiency,with a 5-month history of open wounds from burns
and skin grafts went into regression and full reepithelialization of the
open lesions within 1 month from commencing application of Imunoglukan®.
Patients with post-radiotherapy lesions reported subjective improvement
and accelerated healing of the defects. (MUDr. J.Koller, Head,
Department for Burns and Reconstructive Surgery, University Hospital,
Bratislava, Slovakia,
2002)
• The efficacy of topically applied beta-(1,3/1,6)-Dglucan was confirmed
by the study focused on topical
application of formulations containing beta-(1,3/1,6)-D-glucan during
various types of dermatoses. In the course of application the topical
findings have improved and stabilized. No side effects were observed.
The efficacy of topically applied beta-(1,3/1,6)-D-glucan was also
confirmed by the study that examined the effect of the lotion form: skin
condition in patients suffering from atopic eczema and rosacea faciei
significantly improved during two to four weeks of application and the
anti-aging effect manifested itself markedly. (MUDr. H.Zelenková,
Dermatologie NsP Svidník 1999, DOST 2005)
• A clinical trial confirmed very good curative effects
of the cream containing glucan in the treatment of
crural ulceration (ulcus cruris). The cream was applied
to 121 patients on a daily basis for a period of 21 days.
In 18.2 % of patients the lesions were completely healed within 3 weeks.
In further 32.2 % of patients the diameter of the ulcus was reduced by
more than 50 %, while the reduction by less than 50 % were observed in
41.3 % of patients. The treatment was ineffective in only 8.3 % of
cases. No deterioration of medical condition was recorded. The average
age of patients was 64.4 years, which is quite high and thus the healing
process is naturally more difficult. Moreover, the majority of involved
patients have suffered from the disease for several years without any
successful treatment. (KÚNZ-FN Bratislava, FNsP Košice, FN Martin, 1994)
Producer: Pleuran spol s r.o., Súkennícka 15, 821 09 Bratislava, Slovak
Republic
• In a clinical post-marketing study, Imunoglukan® cream
from the company Pleuran was applied to 27 patients including 16
patients with Acne Vulgaris, 2 patients with Dermatitis seborrhoica, 1
patient with Dermatitis rosaceiformis faceií, 7 patients with Ulcus
cruris and 1 patient with Eczema atopicum. Imunoglukan® cream was
applied 1 to 4 times a day for a period of 6 to 20 days. No subjective
or objective deterioration of medical conditions was observed in or
reported by the patients. A nearly 40 % (38.44 %) reduction of surface
of almost all lesions was detected by the attending physician. The most
significant
improvement in the surface of lesions and erythema
was observed in Dermatitis seborrhoica, Acne vulgaris and Ulcus cruris
patients (the number of patients with respective diagnoses should be
also considered). Particular attention was focused on the evaluation of
the group with Ulcus cruris diagnosis in which the reduction of ulcus
surface of 1.29 cm2 (41 %) was observed.
References:
1) Babineau TJ, Hackford A, Kenler A, et al. A phase II multicenter,
double-blind, randomized,
placebo controlled study of three dosages of an immunomodulator (PGG-glucan)
in high
risk surgical patients. Arch Surg 1994; 129:1204-1210.
2) Browder IW, Sherwood E, Williams D, et al. Protective effect of
glucan-enhanced
macrophage function in experimantal pancreatitis. Am J Surg 1987; 153:
25-33.
3) Czop JK, Valiante NM, Janusz MJ. Phagocytosis of particulate
activators of the human
alternative complement pathway through monocyte beta-glucan receptors.
Prog Clin Biol
Res 1989;297:187-296.
4) Olson EJ, Standing JE, griego-Harper N, et al. Fungal beta-glucan
interacts with vitronectin
and stimulates tumor necrosis factor alpha release from macrophages.
Infect Immun
1996;64:3548-3554.
5) Wursch P, Pi-Sunyer FX. The role of viscouus soluble fiber in the
metabolic control of
diabetes. A review with special emphasis in cereals rich in beta-glucan.
Diabetes Care
1997;20:1774-1780.